Endymed Received FDA Approval for Marketing and Sales of its Brand-New Laser based Hair Removal Device
yahoo.com
finance
2022-10-20 14:02:00

CAESAREA, Israel, Oct. 20, 2022 /PRNewswire/ -- Endymed Ltd (TASE: ENDY), currently traded on the Tel Aviv Stock Exchange, is proud to announce that it has been granted FDA approval for the marketing and sales of Pure Laser, a new hair removal device in the United States.

The Pure Laser was developed in the Company's labs by its subsidiary Endymed Medical Ltd. and is based on laser technology, designed to treat hair removal on all skin types. To obtain the approval, the Company conducted numerous clinical tests to evaluate the device's safety and efficacy.
